Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 400003011000036115 | Blistex Medicated Lip ointment, 8 g | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 400005011000036119 | Blistex Medicated Lip (camphor 10 mg / 1 g + oxybenzone 20 mg / 1 g + padimate-O 75 mg / 1 g) ointment, 8 g (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Blistex Medicated Lip ointment, 8 g | Is a | trade product pack | true | Inferred relationship | Some | ||
| Blistex Medicated Lip ointment, 8 g | Is a | padimate-O 7.5% + oxybenzone 2% + camphor 1% ointment, 8 g | true | Inferred relationship | Some | ||
| Blistex Medicated Lip ointment, 8 g | has TPUU | Blistex Medicated Lip ointment | true | Inferred relationship | Some | 1 | |
| Blistex Medicated Lip ointment, 8 g | has TP | Blistex Medicated Lip | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Blistex Medicated Lip ointment, 8 g, tube | Is a | True | Blistex Medicated Lip ointment, 8 g | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR